Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas. Braunstein Z, Waller A, Dotson E, McLaughlin E, et al. Leuk Lymphoma 2024;65:301-311.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Braunstein Z, Waller A, Dotson E, McLaughlin E, et al. Gemcitabine and liposomal doxorubicin (GemDox) for the treatment of relapsed and refractory T-cell lymphomas. Leuk Lymphoma 2024;65:301-311.
PMID: 38093530